Pharma Trends – January 2024

A patient-centric approach is becoming increasingly important trend in pharma marketing. While this concept isn’t new, ways to leverage it across the brand lifecycle – from clinical research to commercialization – are continuously evolving. Check out these resources on the top pharma trends in January 2024:

3 Ways to Make 2024 the Year of the Patient

Source: pharmaphorum

Author:Steve Rosenberg

Wait, the Doctor-Patient Conversation?

Patient centricity will have a greater impact on the way pharma designs and conducts trials in 2024 and beyond. Create significant improvements in research by focusing on three key areas: 1) Involve patients in trial design and development; 2) Address patients’ increasing technology expectations; 3) Eliminate silos. As these elements come together, we’ll see the patient wield much more of a positive influence on clinical research moving forward.

READ FULL ARTICLE

Involving Patients in Compassion-Based Marketing Programs

Compassion in Healthcare

Source: On-Demand Webinar: What Can Pharma Do About the Compassion Crisis in Medicine?

Integrating the patient perspective is key to incorporating compassion in market-shaping initiatives that help improve treatment adherence and health outcomes for patients. An expert panel hosted by Vision2Voice President Dan Rehal shares their views on the compassion crisis in medicine. They discuss why it matters and how to include patients in medical communications programs to help HCPs deliver compassionate care.

WATCH WEBINAR

Utilizing Patient Engagement Strategies in Pharmaceutical Marketing

Source: pharma-mkting.com

Patient Advocacy Group

The pharmaceutical industry is constantly evolving to meet the needs of patients and healthcare providers. One aspect of this pharma trend is the integration of patient engagement strategies into the marketing of pharmaceutical products. By engaging with patients, pharma companies can better understand their needs and develop products and services that meet those needs. Participating in patient advocacy groups, sponsoring patient education events, and offering tools to promote patient-HCP communication can help increase patient care and product sales.

READ FULL ARTICLE

Recent Posts

KOL/KEE Identification: 3 Common Strategies – Dan Recommends

When an existing client or new client calls me about key opinion leader (KOL) or Key External Expert (KEE) Identification, they have a purpose in...

Read More
KOL Partnerships

Keys to Building Lasting Partnerships with KOLs/ KEEs and DOLs

Top-tier Key Opinion Leaders (KOLs)/ Key External Experts (KEEs) and Digital Opinion Leaders (DOLs) are among the most influential voices in the pharmaceutical industry. Their...

Read More
Digital Opinion Leaders

What’s Trending in the News

We’ve been hearing a lot about the evolution of Digital Opinion Leaders (DOLs), so we’ve curated some articles on this topic and hope you find...

Read More